Morphine withdrawal regulates phosphorylation of cAMP response element binding protein (CREB) through PKC in the nucleus tractus solitarius-A 2 catecholaminergic neurons

Journal of Neurochemistry

Volumn 110, Issue 5, 2009, Pages 1422-1432

  Martín, Fátima ^a   Laorden, M Luisa ^a   Milanés, M Victoria ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

cAMP response element binding protein and tyrosine hydroxylase; Extracellular signal regulated kinase 1 2; Hypothalamo pituitary adrenocortical axis; Morphine withdrawal; Nucleus tractus solitarius A2; Protein kinase C

Indexed keywords

ALPHA [AMINO(4 AMINOPHENYLTHIO)METHYLENE] 2 (TRIFLUOROMETHYL)PHENYLACETONITRILE; CALPHOSTIN C; CORTICOSTERONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHINE; NALOXONE; PROTEIN KINASE C; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; DRUG WITHDRAWAL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOBLOTTING; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SOLITARY TRACT NUCLEUS; STRESS; UPREGULATION;

ANIMALS; CATECHOLAMINES; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; MALE; MORPHINE; NALOXONE; NAPHTHALENES; NEURONS; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SOLITARY NUCLEUS; SUBSTANCE WITHDRAWAL SYNDROME; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 68949217296     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06234.x     Document Type: Article

References (40)

1. Atkins C. M., Selcher J. C., Petraitis J. J., Trzaskos J. M. Sweatt J. D. (1998) The MAPK cascade is required for mammalian associative learning. Nat. Neurosci. 1, 602 609.
2. Benavides M., Laorden M. L., García-Borrón J. C. Milanés M. V. (2003) Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN. Eur. J. Neurosci. 17, 103 112.
3. Benavides M., Laorden M. L., Marin M. T. Milanes M. V. (2005) Role of PKC-alpha,gamma isoforms in regulation of c-Fos and TH expression after naloxone-induced morphine withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups. J. Neurochem. 95, 1249 1258.
4. Berhow M. T., Russel D. S., Terwilliger R. Z., Beitner-Johnson D., Self D. W., Lindsay R. M. Nestler E. J. (1995) Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68, 969 979.
5. Blendy J. A. Maldonado R. (1998) Genetic analysis of drug addiction: the role of cAMP response element binding protein. J. Mol. Med. 76, 104 110.
6. Cerezo M., Laorden M. L. Milanes M. V. (2002) Inhibition of protein kinase C but not proten kinase A attenuates morphine withdrawal excitation of rat hypothalamus-pituitary-adrenal axis. Eur. J. Pharmacol. 452, 57 66.
7. Chao J. Nestler E. J. (2004) Molecular neurobiology of drug addiction. Annu. Rev. Med. 55, 113 132.
8. Cleck J. N. Blendy J. A. (2008) Making a bad thing worse: adverse effects of stress on drug addiction. J. Clin. Invest. 118, 454 461.
9. Deak M., Clifton A. D., Lucocq L. M. Alessi D. R. (1998) Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17, 4426 4441.
10. Funada M., Hara C. Wada K. (2001) Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system. Eur. J. Pharmacol. 430, 277 281.
11. Gabra B. H., Bailey C. P., Kelly E., Smith F. L., Henderson G. Dewey W. L. (2008) Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice. Brain Res. 1217, 70 77.
12. Goodman A. (2008) Neurobiology of addiction. An integrated review. Biochem. Pharmacol. 75, 266 322.
13. Grammer T. C. Blenis J. (1997) Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene 14, 1635 1662.
14. Guitart X., Thompson M. A., Mirante C. K., Greenberg M. E. Nestler E. J. (1992) Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the tar locus coeruleus. J. Neurochem. 58, 1168 1171.
15. Han M.-H., Bolaños C. A., Green T. A., Olson V. G., Neve R. L., Liu R.-J., Aghajanian G. K. Nestler E. J. (2006) Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors. J. Neurosci. 26, 4624 4629.
16. Johannessen M., Delghandi M. P. Moens U. (2004) What turns CREB on? Cell Signal. 16, 1211 1227.
17. Kobayashi E., Nakano H., Morimoto M. Tamaoki T. (1989) Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159, 548 553.
18. Koob G. F. Le Moal M. (2001) Drug addiction, dysregulation of reward and allostasis. Neuropsychopharmacology 24, 97 129.
19. Koob G. F. Le Moal M. (2008) Addiction and the brain antireward system. Ann. Rev. Physiol. 59, 29 53.
20. Kovacs G. L. Telegdy G. (1988) Hypothalamo-neurohypophyseal neuropeptides and experimental drug addiction. Brain Res. Bull. 20, 893 895.
21. Lane-Ladd S. B., Pineda J., Boundy V. A., Pfeuffer T., Krupinsky J., Aghajanian G. K. Nestler E. J. (1997) CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17, 7890 7901.
22. 2-adrenoceptors. J. Pharmacol. Exp. Ther. 293, 578 584.
23. Laorden M. L., Castells M. T. Milanés M. V. (2002a) Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats. Br. J. Pharmacol. 136, 67 75.
24. Laorden M. L., Núñez C., Almela P. Milanés M. V. (2002b) Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones. J. Neurochem. 83, 132 140.
25. Le Moal M. Koob G. F. (2007) Drug addiction: pathways to the disease and pathophysiological perspectives. Eur. Neuropsychopharmacol. 17, 377 393.
26. Lewis-Tuffin L. J., Quinn P. G. Chikaraishi D. M. (2004) Tyrosine hydroxylase transcription depends primarily on cAMP response element activity, regardless of the type of inducing stimulus. Mol. Cell. Neurosci., 25, 536 547.
27. Maldonado R. (1997) Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci. Biobehav. Rev. 1, 91 104.
28. Maldonado R., Blendy J. A., Tzavara E., Gass P., Roques B. P., Haoune J. Schütz G. (1996) Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273, 657 659.
29. Nestler E. J. (2004) Molecular mechanisms of drug addiction. Neuropharmacology 47, 24 32.
30. Nestler E. J. (2005) Is there a common molecular pathway for addiction? Nat. Neurosci. 8, 1445 1449.
31. Núñez C., Foldes A., Laorden M. L., Milanes M. V. Kovács K. J. (2007a) Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. J. Neurochem. 101, 1060 1071.
32. 2 cell group. Role of ERK1. Endocrinology 148, 5780 5793.
33. Núñez C., Castells M. T., Laorden M. L. Milanes M. V. (2008) Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system. N-S Arch. Pharmacol. 378, 407 420.
34. Núñez C., Földes A., Pérez-Flores D., García-Borrón J. C., Laorden M. L., Kovács K. J. Milanés M. V. (2009) Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase (TH) mRNA expression, phosphorylation and enzyme activity in the nucleus of the solitary tract (NTS-A2) during morphine withdrawal. Endocrinology 150, 3118 3127.
35. Pores-Fernando A. T., Gaur S., Grybko M. J. Zweifach A. (2008) ERK activation is only one role of PKC in TCR-independent cytotoxic T cell granule exocytosis. Biochem. Biophys. Res. Commun. 371, 630 634.
36. Rozengurt E. (2007) Mitogenic signaling pathways induced by G protein-coupled receptors. J. Cell. Physiol. 213, 589 602.
37. Shaw-Lutchman T. Z., Barrot M., Wallace T., Gilden L., Zachariou V., Impey S., Duman R. S., Storm D. Nestler E. J. (2002) Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J. Neurosci. 22, 3663 3672.
38. Walters C. L., Kuo Y.-C. Blendy J. A. (2003) Differential distribution of CREB in the mesolimbic dopamine reward pathway. J. Neurochem. 87, 1237 1244.
39. Wong D. L. Tank A. W. (2007) Stress-induced catecholaminergic function: transcriptional and post-transcriptional control. Stress 10, 121 130.
40. Zheng Z. Keifer J. (2008) Protein kinase C-dependent and independent signaling pathways regulate synaptic GluR1 and GluR4 AMPAR subunits during in vitro classical conditioning. Neuroscience 156, 872 884.